Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer.
Rachel B JimenezCaroline SchenkelLaura A LevitBonnie HuXiudong Jennifer LeiRobert Donald HarveyVicki A MorrisonTeri PollastroDavid Michael WaterhouseColin WeekesGrant R WilliamsSuanna Steeby BruinoogeElizabeth Garrett-MayerJeffrey M PeppercornPublished in: JCO oncology practice (2022)
Oncology practice varies with regard to discussion and individualized selection of starting doses in the metastatic setting. This study demonstrates a need for consideration of shared decision making regarding initial dose selection and strong support among oncologists for clinical studies to define optimal dosing and best practices for individualizing care.